Lyra Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
08 Oct 2025	Form 4/A: Palasis Maria, Director Holds 0 Employee Stock Option (right to buy) (exercise price $303.50, expires Mar 20, 2034)
12 Jul 2023	Form 4/A: Palasis Maria, Director Granted 150,000 Stock Option

Comments